A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This 3 arm study will evaluate the efficacy and safety of adding Avastin versus placebo to a
standard chemotherapeutic regimen in patients with advanced or recurrent non-squamous
non-small cell lung cancer (NSCLC) who have not received prior chemotherapy. The anticipated
time of study treatment is until disease progression, and the target sample size is 500+
individuals.